C8orf4 is a transforming growth factor B induced transcript downregulated in metastatic colon cancer

Joshua B Friedman1, Elaine B Brunschwig, Petra Platzer

  • 1Department of Genetics, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH 44106, USA.

Insights

Transforming growth factor-beta (TGF-β) regulates a tumor suppressor pathway in colon cells. This study identified C8orf4 as a TGF-β-induced gene that is lost in advanced colon cancer, suggesting a role in growth regulation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gastroenterology

Background:

  • Transforming growth factor-beta (TGF-β) signaling is crucial for tumor suppression in human colon epithelial cells.
  • Identifying novel genes regulated by TGF-β in the colon is essential for understanding colon cancer development.

Purpose of the Study:

  • To identify and characterize novel genes induced by TGF-β in colon cells.
  • To determine if these TGF-β-induced genes are downregulated in metastatic colon cancer.

Main Methods:

  • Expression microarrays were used to identify TGF-β-induced transcripts in a colon adenoma cell line (Vaco 330).
  • Microarrays were employed to assess TGF-β-induced transcript downregulation in metastatic colon cancer.
  • Northern analysis and real-time reverse transcription PCR validated and quantified gene expression changes.

Main Results:

  • C8orf4 was identified as a gene induced by TGF-β in colon cells.
  • C8orf4 is expressed in normal colon mucosa but significantly downregulated in colon cancer metastases and cell lines.
  • Reduced C8orf4 expression was observed in primary colon tumors compared to normal mucosa.

Conclusions:

  • C8orf4 is a novel TGF-β-regulated gene in colon epithelial cells.
  • Loss of C8orf4 expression in advanced colon cancer suggests its potential role in colon cell differentiation or growth regulation.
  • C8orf4 may serve as a potential biomarker or therapeutic target in colon cancer.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...